Clinical Trials Sponsored by Pegasus Pharmaceuticals Group Inc.
Review Study #000 |
Pandimex IV |
Careseng Vancouver Naturopathic Clinic,
Vancouver, BC, Canada |
2000 – 2004 |
Study #001 |
Careseng oral formulation |
Harbor-UCLA Medical Center, Torrance, California, USA |
Jun 2002 – Suspended |
Study #002 |
Pandimex IV |
Fuzhou General Hospital, China |
Apr 2004 – Jul 2004 |
Study #003 |
Pandimex IV |
No.1 Hospital of Yichun City, China |
Apr 2005 – Mar 2006 |
Study CIH |
Careseng oral formulation |
Centre for Integrative Healing & UBC, Vancouver, BC, Canada |
Feb 2005 – Jul 2005 |
Clinical Trial #G01 |
Pandimex IV (HemoMex I) |
National Oncology Center, Republic of Georgia |
Apr 2007-Nov 2009 |
Clinical Trial #G02 |
SG2 softgel (HemoMex S) |
National Oncology Center, Republic of Georgia |
Aug 2008-Mar 2010 |
Clinical Trial #G03 |
SG2 softgel (HemoMex S) |
National Oncology Center, Republic of Georgia |
Aug 2008-Mar 2010 |
Clinical Trial # G04 |
Pandimex IV & SG2 (HemoMex I & HemoMex S) |
National Oncology Center, Republic of Georgia |
Apr 2007- Apr 2010 |
Clinical Trial #A01 |
SG2 softgel (HemoMex S) |
National Oncology Center, Republic of Armenia |
Oct 2009- May 2010 |
